logo-loader

Avacta Group PLC agrees major co-development partnership with US business

Published: 21:20 25 Jul 2018 AEST

Alastair Smith, chief executive of Avacta Group Plc (LON: AVCT), discusses with Proactive's Andrew Scott a co-development partnership that's been agreed with a US business.

Smith says they're teaming up with Bach BioSciences, a company commercialising the research of William Bachovchin, a professor at Tufts University School of Medicine, Boston.

In what is described as a “ground-breaking” co-invention, the two companies have developed a new class of drug conjugate for cancer.

Poseidon Nickel signs binding agreement with Mineral Resources to divest...

Departing Poseidon Nickel Ltd (ASX:POS, OTC:PSDNF) CEO Craig Jones and incoming CEO Brendan Shalders join Proactive’s Jonathan Jackson to discuss the divestment of Lake Johnston to Mineral Resources Ltd (ASX:MIN). Jones, who has played a pivotal role in this strategic move, shared insights on...

8 hours, 27 minutes ago